1 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D00426
D00426
|
Risperidone
| [5] 8 8, 156, 179, 187, 206 |
2 |
AGTR1
| [16] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy | D08146
D08146
|
Losartan
| [17] 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
3 |
HTR2A
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D00426
D00426
|
Risperidone
| [5] 8 8, 156, 179, 187, 206 |
4 |
KCNJ11
| [3] Insulin secretion Insulin secretion, GnRH secretion, Type II diabetes mellitus | D00418
D00418
|
Minoxidil
| [1] 179 179 |
5 |
SLC6A2
| [1] Synaptic vesicle cycle Synaptic vesicle cycle | D04999
D04999
|
Methylphenidate
| [2] 179 179, 206 |
6 |
SLC6A3
| [7] Synaptic vesicle cycle Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism | D04999
D04999
|
Methylphenidate
| [7] 6 6, 13, 34, 84, 113, 179, 206 |
7 |
SLC6A4
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | D00326
D00326
|
Fluoxetine
| [6] 13 13, 17, 78, 86, 179, 206 |
8 |
ABCC8
| [3] ABC transporters ABC transporters, Insulin secretion, Type II diabetes mellitus | D00418
D00418
|
Minoxidil
| [1] 179 179 |